Lv4
460 积分 2026-05-15 加入
美泊利珠单抗治疗嗜酸性肉芽肿性多血管炎的疗效及安全性分析
1个月前
已完结
Validation of the 2022 ACR/EULAR classification criteria for eosinophilic granulomatosis with polyangiitis in a Chinese cohort
1个月前
已完结
Efficacy and safety of filgotinib as induction and maintenance therapy for Crohn's disease (DIVERSITY): a phase 3, double-blind, randomised, placebo-controlled trial
2个月前
已完结
The role of complement in kidney disease
2个月前
已完结
Real-world safety profile of eculizumab in patients with paroxysmal nocturnal hemoglobinuria, atypical hemolytic uremic syndrome, or generalized myasthenia gravis: an integrated analysis of post-marketing surveillance in Japan
2个月前
已完结
Efficacy and safety of complement inhibitors in IgAN: a systematic review and meta-analysis
2个月前
已完结
Outcome of atypical hemolytic uremic syndrome: role of triggers and complement abnormalities in the response to C5 inhibition
2个月前
已完结
Atypical hemolytic uremic syndrome in the era of terminal complement inhibition: an observational cohort study
2个月前
已完结
The susceptibility of the kidney to alternative pathway activation—A hypothesis
2个月前
已完结
Anti-drug antibodies of IL-17 inhibitors for psoriasis: a systematic review
2个月前
已完结
皖公网安备34019202002308
